The policy revelation shows just how eager Novartis is in addressing some latest ethics shortfalls.

Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.

Drug manufacturers were shaking off the remnants of Hurricane Florence on Monday after the dangers from the storm morphed into hazardous flooding.

AstraZeneca’s latest data on its triple-combination COPD candidate may not do much to help it against rival GlaxoSmithKline.

The new eczema data came a month ahead of an expected FDA decision on the drug's fate in asthma.

As it works to turn its business around, Teva picked up an important FDA approval for migraine prevention medication Ajovy.

Sticker prices in drug ads might be off the table again, thanks to some in the U.S. House of Representatives.

Patient groups are asking CVS to reconsider its move to allow clients to exclude drugs based on guidance from drug cost watchdog ICER.